Ignite Creation Date:
2025-12-24 @ 7:13 PM
Ignite Modification Date:
2026-01-04 @ 12:42 PM
Study NCT ID:
NCT03760003
Status:
COMPLETED
Last Update Posted:
2025-11-28
First Post:
2018-11-29
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Dose-Ranging Phase 2b Study of ABX464 in Moderate to Severe Ulcerative Colitis
Sponsor:
Abivax S.A.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
ABX464-103
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None